Table 3.

Preclinical pharmacological and toxicological/safety studies of AYUSH-64 and its ingredients.

S. No	Preclinical pharmacological and toxicological/safety studies
1.	In albino mice, oral administration of AYUSH-64 at doses of 250–750 mg/kg for five days exhibited significant anti-malarial property [67].
2.	The experimental studies of AYUSH-64 have shown that it was safe and non-toxic in a dose of 500 mg/kg of body weight for 12 weeks [67].